UPDATE: Dahlman Rose Downgrades Molycorp to Hold on Capital Requirements
Dahlman Rose downgraded Molycorp (NYSE: MCP) from Buy to Hold.
Dahlman Rose commented, "In the company's 8-K, filed alongside its proposed $300MM capital raise announcement, management alluded to an additional $130MM in capex for 2013. We are downgrading Molycorp to Hold from Buy, based on unanticipated additional scaling up of capital requirements."
Molycorp closed at $7.97 on Tuesday.
Latest Ratings for MCP
|Aug 2014||Euro Pacific||Downgrades||Hold||Sell|
|Aug 2014||Euro Pacific||Upgrades||Sell||Hold|
|May 2014||Morgan Stanley||Downgrades||Underweight|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.